Glioblastoma Multiforme Formation and EMT: Role of FoxM1 Transcription Factor

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|21|10|1268-1271

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.21, Iss.10, 2015-03, pp. : 1268-1271

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A new target for proteasome inhibitors: FoxM1

By Gartel Andrei L  

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 2, 2010-02 ,pp. : 235-242

Informa Healthcare

Access to resources Recommend Favorite

Glioblastoma Multiforme Imaging: The Role of Nuclear Medicine

By  

Current Radiopharmaceuticals, Vol. 5, Iss. 4, 2012-10 ,pp. : 308-313

Bentham Science Publishers

Access to resources Recommend Favorite

The Emerging Role of Stereotactic Radiosurgery in the Treatment of Glioblastoma Multiforme

By  

Current Radiopharmaceuticals, Vol. 5, Iss. 4, 2012-10 ,pp. : 292-299

Bentham Science Publishers

Access to resources Recommend Favorite

Role of microRNAs in gliomagenesis: targeting miRNAs in glioblastoma multiforme therapy

By Nikaki Alexandra   Piperi Christina   Papavassiliou Athanasios G  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 10, 2012-10 ,pp. : 1475-1488

Informa Healthcare

Access to resources Recommend Favorite

Editorial: [Hot Topic: The Role of Nuclear Medicine in the Management of Patients with Glioblastoma Multiforme]

By  

Current Radiopharmaceuticals, Vol. 5, Iss. 4, 2012-10 ,pp. : 289-291

Bentham Science Publishers

Access to resources Recommend Favorite